Lista de obras -

A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study

artículo científico publicado en 2018

A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye.

artículo científico publicado en 2017

Allergic conjunctivitis: a cross-sectional study

artículo científico publicado en 2015

Allergy and allergic mediators in tears ⬇️

artículo científico publicado el 25 de julio de 2013

Allergy and the eye.

artículo científico publicado en 2008

Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis

artículo científico publicado en 2006

Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments

artículo científico publicado en 2007

Atmospheric-Pressure Cold Plasma Induces Transcriptional Changes in Ex Vivo Human Corneas

artículo científico publicado en 2015

Author's Reply to: "Concerns Over: Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease"

artículo científico publicado en 2017

Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study

artículo científico publicado en 2006

Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease

artículo científico publicado en 2020

Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli

artículo científico publicado en 2015

Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva

artículo científico publicado en 2010

Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc(epsilon)RI, the high-affinity receptor for immunoglobulin E

scientific article published on 19 December 2008

Clinical Patterns of Ocular Anaphylaxis in Guinea Pigs Passively Sensitized with IgGl Antibody ⬇️

artículo científico publicado el 1 de enero de 1990

Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients

artículo científico publicado en 2007

Conjunctival Mast Cells and the Allergic Late Phase Reaction ⬇️

artículo científico publicado el 1 de enero de 1992

Conjunctival allergen provocation test : guidelines for daily practice.

artículo científico publicado en 2016

Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis

artículo científico publicado en 2020

Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy

scientific article published on 10 August 2019

Corneal Confocal Microscopy in Patients with Vernal Keratoconjunctivitis ⬇️

artículo científico publicado el 15 de diciembre de 2011

Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine

scientific article published on 10 April 2020

Corneal staining patterns in vernal keratoconjunctivitis: the new VKC-CLEK scoring scale

artículo científico publicado en 2018

Cytokine and chemokine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment.

artículo científico publicado en 2009

Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients

artículo científico publicado en 2009

Diagnostic tools in ocular allergy.

artículo científico publicado en 2017

Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma

artículo científico publicado en 2012

Does Ocular Neuropathic Pain Deserve an Autonomous Position in the IHS Classification? Clinical and Diagnostic Evidences.

artículo científico publicado en 2017

Double Hapten Challenge in Guinea Pigs Undergoing an Ocular Late-Phase Reaction ⬇️

artículo científico publicado el 1 de enero de 1991

Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro

artículo científico publicado en 2003

Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts.

artículo científico publicado en 2003

Effects of cyclosporin A on human conjunctival fibroblasts

artículo científico publicado en 2001

Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops

scientific article published on 10 October 2018

Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

artículo científico publicado en 2018

Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial

artículo científico publicado en 2016

Efficacy and safety of desonide phosphate for the treatment of allergic conjunctivitis

artículo científico publicado en 2002

Emerging drugs for ocular allergy

artículo científico publicado en 2005

Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis

artículo científico publicado en 1995

Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study

artículo científico

Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis

artículo científico publicado en 2011

Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts

artículo científico publicado en 2002

ICON: Diagnosis and management of allergic conjunctivitis

scientific article published on 21 November 2019

Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics.

artículo científico publicado en 2013

Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities

artículo científico publicado en 2007

In vitro effects of fluoroquinolone and aminoglycoside antibiotics on human keratocytes

artículo científico publicado en 2006

In-vivo diagnostic measurements of ocular inflammation

artículo científico publicado en 2005

Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies

artículo científico publicado en 2018

Keratitis in Dry Eye Disease and Topical Ciclosporin A.

artículo científico publicado en 2017

Management of ocular allergy

scientific article published on 24 June 2019

Management of vernal keratoconjunctivitis

artículo científico publicado en 2013

Managing ocular allergy in the time of COVID-19

scientific article published on 13 May 2020

Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis

artículo científico publicado en 2015

Ocular Surface Expression of SARS-CoV-2 Receptors

artículo científico publicado en 2020

Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.

artículo científico

Office-based ocular procedures for the allergist

artículo científico publicado en 2019

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

scientific article published on April 2010

One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease.

artículo científico publicado en 2017

Pan-European survey of the topical ocular use of cyclosporine A.

artículo científico publicado en 2017

Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-Label Extension of the SANSIKA Study

scientific article published on 30 October 2018

Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Prevalence of vernal keratoconjunctivitis: a rare disease?

artículo científico publicado en 2008

Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy ⬇️

artículo científico publicado en 2010

Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.

artículo científico publicado en 2009

Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model

artículo científico publicado en 2002

Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy.

artículo científico publicado en 2015

Tailored Approach to the Treatment of Vernal Keratoconjunctivitis

artículo científico publicado en 2010

Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis

scientific article published on 01 March 2003

Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases

scientific article published on 01 February 2000

Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis

scientific article published on 01 July 2003

Th1- and Th2-type cytokines in chronic ocular allergy

artículo científico publicado en 2006

The central role of conjunctival mast cells in the pathogenesis of ocular allergy

artículo científico publicado en 2002

The multifaceted aspects of ocular allergies: Phenotypes and endotypes

artículo científico publicado en 2022

Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study

artículo científico publicado en 2011

Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.

artículo científico publicado en 1990

Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing

artículo científico publicado en 2022

Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis.

artículo científico publicado en 2010

Trypsin inhibitory capacity in vernal keratoconjunctivitis

scientific article published on 01 January 2007

Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis

scientific article published on 01 August 2003

Twelve-Month Results of Cyclosporine A Cationic Emulsion in a Randomized Study in Patients With Pediatric Vernal Keratoconjunctivitis

scientific article published on 23 November 2019

Urban eye allergy syndrome: a new clinical entity?

artículo científico publicado en 2008

Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis

artículo científico publicado en 2005

Vernal keratoconjunctivitis

artículo científico publicado en 2015

Vernal keratoconjunctivitis

artículo científico publicado en 2003

Vernal keratoconjunctivitis-like disease in adults.

artículo científico publicado en 2013

Vernal keratoconjunctivitis: pathogenesis and treatment

artículo científico publicado en 2002

Lista de obras de

A Randomized, Controlled Trial of Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: The VEKTIS Study

A randomized study of the efficacy and safety of 0.1% cyclosporine A cationic emulsion in treatment of moderate to severe dry eye.

Allergic conjunctivitis: a cross-sectional study

Allergy and allergic mediators in tears ⬇️

Allergy and the eye.

Altered Expression of Neurotransmitter Receptors and Neuromediators in Vernal Keratoconjunctivitis

Antibody array characterization of inflammatory mediators in allergic and normal tears in the open and closed eye environments

Atmospheric-Pressure Cold Plasma Induces Transcriptional Changes in Ex Vivo Human Corneas

Author's Reply to: "Concerns Over: Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease"

Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study

Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease

Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli

Characterisation of the phenotype and function of monocyte-derived dendritic cells in allergic conjunctiva

Characterization of dendritic cell phenotype in allergic conjunctiva: increased expression of Fc(epsilon)RI, the high-affinity receptor for immunoglobulin E

Clinical Patterns of Ocular Anaphylaxis in Guinea Pigs Passively Sensitized with IgGl Antibody ⬇️

Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patients

Conjunctival Mast Cells and the Allergic Late Phase Reaction ⬇️

Conjunctival allergen provocation test : guidelines for daily practice.

Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis

Cornea verticillata in Fabry disease: a comparative study between slit-lamp examination and in vivo corneal confocal microscopy

Corneal Confocal Microscopy in Patients with Vernal Keratoconjunctivitis ⬇️

Corneal Microstructural Changes by Confocal Microscopy in Vernal Keratoconjunctivitis Patients Treated with Topical Cyclosporine

Corneal staining patterns in vernal keratoconjunctivitis: the new VKC-CLEK scoring scale

Cytokine and chemokine levels in tears and in corneal fibroblast cultures before and after excimer laser treatment.

Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients

Diagnostic tools in ocular allergy.

Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma

Does Ocular Neuropathic Pain Deserve an Autonomous Position in the IHS Classification? Clinical and Diagnostic Evidences.

Double Hapten Challenge in Guinea Pigs Undergoing an Ocular Late-Phase Reaction ⬇️

Effect of ofloxacin and netilmicin on human corneal and conjunctival cells in vitro

Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts.

Effects of cyclosporin A on human conjunctival fibroblasts

Efficacy and Tolerability of Ketotifen in the Treatment Of Seasonal Allergic Conjunctivitis: Comparison between Ketotifen 0.025% and 0.05% Eye Drops

Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial

Efficacy and safety of desonide phosphate for the treatment of allergic conjunctivitis

Emerging drugs for ocular allergy

Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis

Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study

Histamine H4 receptors in normal conjunctiva and in vernal keratoconjunctivitis

Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts

ICON: Diagnosis and management of allergic conjunctivitis

Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics.

Immunopathogenesis of ocular allergy: a schematic approach to different clinical entities

In vitro effects of fluoroquinolone and aminoglycoside antibiotics on human keratocytes

In-vivo diagnostic measurements of ocular inflammation

Intravitreal Sirolimus for the Treatment of Noninfectious Uveitis: Evolution through Preclinical and Clinical Studies

Keratitis in Dry Eye Disease and Topical Ciclosporin A.

Management of ocular allergy

Management of vernal keratoconjunctivitis

Managing ocular allergy in the time of COVID-19

Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis

Ocular Surface Expression of SARS-CoV-2 Receptors

Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.

Office-based ocular procedures for the allergist

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.

One-year efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease.

Pan-European survey of the topical ocular use of cyclosporine A.

Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-Label Extension of the SANSIKA Study

Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis

Prevalence of vernal keratoconjunctivitis: a rare disease?

Profile of lipid and protein autacoids in diabetic vitreous correlates with the progression of diabetic retinopathy ⬇️

Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population.

Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model

Small fiber peripheral neuropathy in Wilson disease: an in vivo documentation by corneal confocal microscopy.

Tailored Approach to the Treatment of Vernal Keratoconjunctivitis

Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis

Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases

Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis

Th1- and Th2-type cytokines in chronic ocular allergy

The central role of conjunctival mast cells in the pathogenesis of ocular allergy

The multifaceted aspects of ocular allergies: Phenotypes and endotypes

Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study

Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.

Tracing the SARS-CoV-2 infection on the ocular surface: Overview and preliminary corneoscleral transcriptome sequencing

Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis.

Trypsin inhibitory capacity in vernal keratoconjunctivitis

Tumor necrosis factor-alpha (TNF-alpha) in seasonal allergic conjunctivitis and vernal keratoconjunctivitis